FEATURE
YEMAACHI BIOTECH ACCELERATES AI-DRIVEN GENOMIC DISCOVERY POWERED BY THE NEXSAN UNITY NV10000
Yemaachi BioTech is harnessing sovereign AI-ready infrastructure to process petabyte-scale genomic datasets locally and accelerate precision medicine research across Africa. Powered by the BlueNODE platform from BlueSPACE and anchored by the Nexsan Unity NV10000, the deployment delivers the high-performance storage and compute needed to drive advanced Machine Learning workloads under full local control.
frican genomics is undergoing
A a profound shift as research organisations gain access to advanced, sovereign AI infrastructure built directly on the continent.
Yemaachi BioTech, one of Africa’ s most forwardlooking precision medicine companies, sits at the centre of this transformation. Its mission is ambitious: decode African genomic diversity at scale and apply Machine Learning to uncover biomarkers, disease susceptibilities and therapeutic insights that have long been overlooked in global research.
Achieving this requires not only scientific expertise but an extraordinary level of data infrastructure capable of handling petabytes of genomic information with the speed, reliability and security demanded by AI-driven workflows.
David Hutchful, COO, Yemaachi BioTech www. intelligentcio. com
INTELLIGENT CIO AFRICA
35